Findings Rating Scales

Categorical endpoints are frequently summarized in clinical trials and are often included within the Questionnaires (QS) domain, where patients choose from a limited number of predefined responses to specific survey questions. However, categorical endpoints are not exclusive to the QS domain and might be included in other domains to summarize endpoints with a limited number of levels, such as rating scales. For example, subjective endpoints that describe patient-reported symptoms might be reported using a scale with the following character and corresponding numeric values:

• None (0)
• Mild (1)
• Moderate (2)
• Severe (3)
• Very Severe (4)

Similar scales might be used by physicians to describe the overall severity of various aspects of a disease. Other possibilities include scales that describe the level of agreement to particular statements:

• Strongly Disagree (-2)
• Disagree (-1)
• Neutral (0)
• Agree (1)
• Strongly Agree (2)

or binary outcomes that describe whether an endpoint was successful:

• Failure (0)
• Success (1)

The new Findings Rating Scales report analyzes endpoints from findings domains with a limited number of levelsand presents results by Visit. In general, tests can be analyzed when they have both character values (even when those values are numeric) and corresponding numeric values, similar to the scales presented above.

Methodology

Outcome is a method for evaluating change in a test from the Baseline visit to a non-Baseline visit using a three-level endpoint that answers the question “Did values decrease, increase, or remain the same?”. Our scale here is:

• None (0)
• Mild (1)
• Moderate (2)
• Severe (3)
• Very Severe (4)

The report requirement for the corresponding numeric values makes it possible to calculate the number of levels changed. Some simple examples are provided for illustration:

• A patient who improves from Severe (3) at Baseline to None (0) at Week 4 Decreases by 3 levels, because 0 – 3 = 3.
• A patient who worsens from Moderate (2) at Baseline to Very Severe (4) at Week 4 Increases by 2 levels, because 4 – 2 = 2.
• A patient who is Moderate (2) at Baseline and Moderate (2) at Week 4 experiences no change and has a Neutral response, because 2 – 2 = 0.

One final note about Outcome and the Achieving a minimum or maximum value meets outcome criteria option before reviewing the output. Selecting this option requires that the Minimum and Maximum values of each scale be known. JMP Clinical attempts to derive these values for each test based on the observed values in the selected Domain. However, it is entirely possible that the true Minimum and Maximum values might not be observed during the clinical trial. Users can review and modify these values, if necessary, before performing the analysis. This is described below.

Usage and Interpretation

In general, results are presented by Visit for a single endpoint at a time. If the Time point is available, results are presented by Visit and Time point for a single endpoint. The Data Filter is used to select different endpoints and Time points for review.

A limited artificial example with the single symptom Foreign Body Sensation (FBS) is used here to describe the report and output (measured with None, Mild, Moderate, Severe, Very Severe).

Note: Click on the figures below to enlarge.

Example: 50 patients were randomized to one of three treatments (High Dose, Low Dose, and Placebo) across four Visits (Baseline, Week 2, Week 4, and Week 6).

Options

Data

Autorun this Report

Domain

Findings Tests

Remove Unscheduled visits

Calculate baseline using

Among duplicates, select observations where the numeric value is

Exclude tests exceeding this many levels

Display

Display

Y-Axis

Threshold

Achieving a minimum or maximum value meets outcome criteria

Separate neutral outcomes

Report Filter

Action Buttons

Action buttons provide an easy way for you to drill down into your data. The following action buttons are generated by this report:

Default Settings

Refer to Set Study Preferences for default Subject Level settings.